Refine your search
33 trials found for Cancer, New York City
Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

Clinical trials exploring mevrometostat as a potential treatment for metastatic prostate cancer.

Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.
Carcinoma, Non-Small-Cell Lung
Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma
Colorectal Neoplasms
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous
Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung
Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer, Malignant Neoplasms, Brain Neoplasms, Colorectal Cancer
Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms, Metastatic Breast Cancer, Metastatic Gastric Cancer, Advanced Breast
Urothelial Carcinoma
Urothelial Carcinoma
Urothelial Carcinoma
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.